Seed VC · Cheltenham, United Kingdom
Biovance Capital invests in disruptive, early-stage biopharma companies across Europe, supporting the development of transformational therapies across all modalities and therapeutic areas, working closely with portfolio companies to bring novel medical treatments to patients in need.
Business models
biotech_therapeutics
Customer segments
Researchers, Patients
Geography
Europe, Portugal
We never publish partner emails directly — score your deck to unlock contacts for the firms ranked as best-fit.
Biovance Capital writes first institutional checks where the founder + early product matter more than traction. The seed market is the most dispersed segment of venture; matching to thesis (sector, stage, geography) is where most cold outreach succeeds or fails. VCboom tracks Biovance Capital alongside 47,000+ other active investors, ranked weekly by recent-deal momentum, sector concentration, and partner activity.
Seed VC
Aloe Private Equity
deeptech, biotech
Seed VC
Vickers Venture Partners
deep tech, clean energy, biotech
Seed VC
Advice Capital
biotech, global equities
Seed VC
CRV
DeepTech, AI, Industry 4.0 / Robotics
Seed VC
Boğaziçi Ventures
artificial intelligence, game and technology, robotics and space technology
Seed VC
Gold Nest Capital
life sciences, healthcare, biotech
Drop your pitch. AI scores it on the 8 dimensions VCs read for and ranks the 47,000+ active investors in the database by fit. Biovance Capital is one of them — and we'll tell you exactly where they sit in your top 100.